MARKET

SIGA

SIGA

Siga Technologie
NASDAQ
2.740
-0.150
-5.19%
After Hours: 2.727 -0.013 -0.49% 19:30 11/13 EST
OPEN
2.880
PREV CLOSE
2.890
HIGH
2.920
LOW
2.710
VOLUME
688.45K
TURNOVER
--
52 WEEK HIGH
6.29
52 WEEK LOW
2.710
MARKET CAP
196.88M
P/E (TTM)
-69.3671
1D
5D
1M
3M
1Y
5Y
1D
SIGA Technologies Earnings Call Highlights Growth and Risks
TipRanks · 9h ago
SIGA Technologies, Inc. Reports $15 Million Procurement Contract and Financial Results for Three and Nine Months Ended September 30, 2026
NASDAQ · 5d ago
SIGA Technologies GAAP EPS of -$0.04, revenue of $1.3M
Seeking Alpha · 5d ago
SIGA Technologies Q3 EPS $(0.04) Up From $(0.09) YoY, Sales $1.317M Down From $2.620M YoY
Benzinga · 5d ago
Press Release: SIGA Announces Retirement of Chief Scientific Officer Dennis Hruby, Ph.D.
Dow Jones · 5d ago
Press Release: SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2026
Dow Jones · 5d ago
Weekly Report: what happened at SIGA last week (1102-1106)?
Weekly Report · 6d ago
Weekly Report: what happened at SIGA last week (1026-1030)?
Weekly Report · 11/02 09:15
More
About SIGA
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company. The Company is focused on the development of medicines to treat and prevent infectious diseases. Its flagship product, TPOXX (tecovirimat), is an antiviral medicine approved in the United States and Canada for the treatment of smallpox and authorized in Europe, the United Kingdom, and Japan for the treatment of smallpox, monkeypox (mpox), cowpox, and vaccinia complications. TPOXX specifically inhibits the activity of a protein called VP37, found on the surface of all orthopoxviruses. This prevents the virus from leaving infected cells, slowing the spread of the infection and limiting it to a point where the immune system can clear the virus. The European Medicines Agency and United Kingdom approvals include labeling for oral tecovirimat indicating its use for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox.

Webull offers SIGA Technologies Inc stock information, including NASDAQ: SIGA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SIGA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SIGA stock methods without spending real money on the virtual paper trading platform.